Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adagio Medical Holdings (ADGM) Finished Goods (2023 - 2026)

Adagio Medical Holdings has reported Finished Goods over the past 4 years, most recently at $37000.0 for Q1 2026.

  • Quarterly Finished Goods fell 94.42% to $37000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $37000.0 through Mar 2026, down 94.42% year-over-year, with the annual reading at $86000.0 for FY2025, 82.63% down from the prior year.
  • Finished Goods was $37000.0 for Q1 2026 at Adagio Medical Holdings, down from $86000.0 in the prior quarter.
  • Over five years, Finished Goods peaked at $1.1 million in Q3 2024 and troughed at $37000.0 in Q1 2026.
  • The 4-year median for Finished Goods is $340000.0 (2024), against an average of $441500.0.
  • Year-over-year, Finished Goods plummeted 45.84% in 2024 and then crashed 94.42% in 2026.
  • A 4-year view of Finished Goods shows it stood at $914000.0 in 2023, then tumbled by 45.84% to $495000.0 in 2024, then crashed by 82.63% to $86000.0 in 2025, then plummeted by 56.98% to $37000.0 in 2026.
  • Per Business Quant, the three most recent readings for ADGM's Finished Goods are $37000.0 (Q1 2026), $86000.0 (Q4 2025), and $69000.0 (Q3 2025).